Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04129346 · ClinicalTrials.gov registry record · NA
Technology-Supported Physical Activity Intervention for Metastatic Breast Cancer Survivors: Fit2ThriveMB
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 49
- Enrollment target
NCT04129346 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 49 participants.
The verdict
NCT04129346, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 49 participants
- Enrollment target
Study Summary
This study will test the feasibility and acceptability of increasing PA in metastatic breast cancer (MBC) patients using a smartphone app, fitbit and coaching.
Interventions
- BEHAVIORAL Fitbit
- BEHAVIORAL Fit2ThriveMB App
- BEHAVIORAL Physical Activity Coaching Calls
- BEHAVIORAL Healthy Living Coaching Calls
- BEHAVIORAL Cancer.net app
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2019-11-26 |
| Est. Completion | 2021-05-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04129346
The ClinicalTrials.gov registry entry for NCT04129346 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Fitbit is the first listed.
NCT04129346 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04129346 about?
NCT04129346 is a clinical study titled "Technology-Supported Physical Activity Intervention for Metastatic Breast Cancer Survivors: Fit2ThriveMB". This study will test the feasibility and acceptability of increasing PA in metastatic breast cancer (MBC) patients using a smartphone app, fitbit and coaching.
What is the current status of trial NCT04129346?
This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2019-11-26. Estimated completion is 2021-05-01.
What interventions are being tested in trial NCT04129346?
The interventions under investigation include: Fitbit (BEHAVIORAL), Fit2ThriveMB App (BEHAVIORAL), Physical Activity Coaching Calls (BEHAVIORAL), Healthy Living Coaching Calls (BEHAVIORAL), Cancer.net app (BEHAVIORAL).
Who is sponsoring clinical trial NCT04129346?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.